Vascular Biology and Stromal Targeting Archives - Harry Perkins Institute of Medical Research

About Us
About Perkins

Since 1998, the Perkins has grown to become one of the nation's leading adult medical research centres, where a close-knit team of more than 450 research and clinical staff work together to defeat the major diseases that impact our community.
Research
Research

Perkins researchers focus on some of the major diseases that affect our community. In particular we focus on cancer, diabetes, heart disease and neuromuscular diseases.
Support the Perkins
Support the Perkins

Your support will help us to deliver a healthier future through medical breakthroughs, new treatments and fostering the next generation of scientific talent.
Get Involved
Get Involved

You can support Perkins work in many different ways. From participating in an event, to attending a workshop in the BioDiscovery Centre, to volunteering your time, or supporting our research, we welcome your involvement.
Donate

awards Bioimaging Research and Innovation for Translational Engingeering BRITE Biomedical engineering Blood Vessels Breast Cancer Cancer Cardiovascular Disease Cardiovascular Science and Diabetes Program Imaging and Therapy Media Releases News & Events Vascular Biology and Stromal Targeting Vascular Engineering

Bioengineers deliver innovation award success

By Alicia Bienkowski | awards, Bioimaging Research and Innovation for Translational Engingeering BRITE, Biomedical engineering, Blood Vessels, Breast Cancer, Cancer, Cardiovascular Disease, Cardiovascular Science and Diabetes Program, Imaging and Therapy, Media Releases, News & Events, Vascular Biology and Stromal Targeting, Vascular Engineering

Combining engineering thinking with medical research has proved a winning formula for four Perth start-up companies linked to the Harry Perkins Institute of Medical Research in Nedlands. They were winners…

Blood Vessels Media Releases News & Events Vascular Biology and Stromal Targeting

Perth start-up wins big at MedTech competition

By Alicia Bienkowski | Blood Vessels, Media Releases, News & Events, Vascular Biology and Stromal Targeting

Perkins biomedical engineer and co-founder of the medical technology start-up VeinTech, Nik Bappoo, and his team took out the prestigious $10,000 Medtronic Prize at this year's 2021 MedTech Actuator Origin…

Blood Vessels Cancer Lab News & Events Research Tumour Blood Vessels Tumours Vascular Biology and Stromal Targeting

New drug limits cancer spreading

By Alicia Bienkowski | Blood Vessels, Cancer, Lab, News & Events, Research, Tumour Blood Vessels, Tumours, Vascular Biology and Stromal Targeting

Most patients die from metastatic cancers, not the primary tumour A research team that recently invented a drug to stop blood vessels from forming a treatment resistant barrier around some…

Cancer and Cell Biology Disease Area Lab News & Events Research Research Area Tumours Vascular Biology and Stromal Targeting

New collaboration to aid the development of drugs to treat cancers

By Marlin Communications | Cancer and Cell Biology, Disease Area, Lab, News & Events, Research, Research Area, Tumours, Vascular Biology and Stromal Targeting

Cancer immunotherapies, including checkpoint blocking antibodies such as MSD’s Keytruda, have shown remarkable results in a number of different cancer types. However the effectiveness of these treatments may be enhanced…

Site by Marlin - A Strategy. Creative. Digital. Agency Dedicated to Non Profit Organisations

Vascular Biology and Stromal Targeting

Bioengineers deliver innovation award success

Perth start-up wins big at MedTech competition

New drug limits cancer spreading

New collaboration to aid the development of drugs to treat cancers

Get in touch

I’m looking for

Connect with us

Important information